Melita Sun Jung
CIK 1962407 · Chief Business Officer · last filed 2025-02-03
Melita Sun Jung is a Chief Business Officer who has filed 3 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for TERN, was dated Feb 3, 2025. Across all open-market trades the lifetime net is +$11.5K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
3
$11.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Chief Business Officer | 2,250 | $52.95 | $119.1K | $11.5K | 2 | 2025-02-03 |
| GPCR | Chief Business Officer | — | $42.93 | — | $0 | 1 | 2023-02-09 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | +2,250 | $11.5K | EDGAR |
| 2024-05-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-09 | GPCR | Buy (P) | — | $0 | EDGAR |